StonvexLoading…
StonvexStonvexStonvexCore line items from BK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.08B | $18.62B | $17.70B | $16.53B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $5.55B | $4.53B | $3.30B | $2.56B |
EPS (Diluted) | $7.40 | $5.80 | $3.89 | $2.88 |
Total Assets | $472.30B | $416.06B | $409.88B | $405.56B |
Total Liabilities | $427.49B | $374.30B | $368.97B | $364.93B |
Cash & Equivalents | $5.11B | $4.18B | $4.92B | $5.03B |
Free Cash Flow OCF − CapEx | $5.18B | $-782.00M | $4.69B | $13.72B |
Shares Outstanding | 688.24M | 717.68M | 759.34M | 808.44M |